pharmaphorum

MARCH 7, 2022

A new company set up to use machine learning to find new anti-infective drugs – ArrePath – has launched onto the scene with $20 million in seed financing from a group of investors including the Boehringer Ingelheim Venture Fund. The Princeton, New Jersey-based startup will use the funding to develop its artificial intelligence and imaging based drug discovery platform, used to identify compounds with new and under-exploited mechanisms of action.

Compounding 137

Compounding 137

indispensable health

MARCH 11, 2022

A Budget Paradox: Prioritizing Pharmacy Operational Efficacy & Improving Patient Outcomes Considering the sharp decline of hospital revenues, one of the key impactors of a hospital budget is the inpatient drug spend. There have been significant increases in drug costs over the past ten years. Medication shortages, new specialty therapies, and FDA drug approvals are some of the primary factors for the rise in hospital medication expenditures.

Hospitals 52

Hospitals Patient Care FDA 52

Roots Analysis

MARCH 11, 2022

Exosomes have been of great interest in the recent years due to the discovery of their potential in so many research and analytic procedures. Exosomes are known to have some unique functions, such as their ability to alter recipient cell bioactivities, acting like intercellular messengers and also having therapeutic potential in disease diagnostics as well as targeted drug delivery.

Immunization 52

Immunization Communication 52

Pharma Mirror

MARCH 11, 2022

As we get older, it becomes more challenging to take care of our bodies. Injuries, aches, and pains are more likely to occur. To combat aging, it’s smart to invest in your physical health. One of the primary ways that people stay healthy in California is by receiving chiropractic care. A chiropractor in Solana Beach CA can help you maintain your health while avoiding future injuries.

52

52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

pharmaphorum

MARCH 7, 2022

The former chair of NHS Digital has slammed the decision to absorb the unit into NHS England as a “significant retrograde step” that could undermine citizens’ rights over their health data. In a letter to the BMJ, Kingsley Manning – who headed NHS Digital between 2013 and 2016 – said that the move is a “grave error” that could threaten the confidentiality and use of patient data.

Documentation 115

Documentation 115

NICE

MARCH 10, 2022

Following the launch of the international strategy for NICE , I’m keen to reflect on the importance of international collaborations and partnerships. The COVID-19 pandemic, the extraordinary pace of healthcare innovation, rising costs and the need for accessible, reliable, up-to-date information, are just a few examples highlighting the importance of shared learning on a global scale.

52

52

Pharma Mirror

MARCH 11, 2022

Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers Tokyo: CPhI Japan 2022 returns as a SMART event – with live exhibition at the Big Sight Exhibition Center in Tokyo (20-22 April) alongside an online networking platform – as CPhI data[1] confirms the country continues to top global ‘API quality’ rankings, with Japanese respondents bullish on growth in 2022 forecasting a CAGR of 14% on average.

52

52

pharmaphorum

MARCH 11, 2022

A consortium led by the Digital Medicine Society (DiMe) has been set up to try to end inequities in access to clinical trials, focusing on the increasing number of studies that use digital devices to allow participation. The organisation has teamed up with drugmakers GlaxoSmithKline and Amgen as well as partners in the clinical research, patient engagement and data analytics sector on a project to develop the principles that can be used to make sure trials are designed from the ground up to allo

111

111

Roots Analysis

MARCH 9, 2022

Over the years, the rising popularity of biologics has led to a paradigm shift in the healthcare industry. In the last decade alone, the annual number of approvals of biopharmaceuticals (including monoclonal antibodies, recombinant proteins, vaccines, and gene therapies), by the US FDA, have steadily risen. In fact, over 8,000 biological pharmaceutical products are currently under clinical investigation worldwide. .

Vaccines 52

Vaccines Dosage Immunization FDA 52

Outsourcing Pharma

MARCH 10, 2022

Patient-centric company Belong.life has developed an app designed to inform cancer research by offering a holistic view of the lives of people with cancer.

52

52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Mirror

MARCH 11, 2022

Casimir Further Differentiates Emmes’ Industry-Leading Rare Disease Research Capabilities Rockville, MD, March 10, 2022 – Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that it has acquired Casimir, a U.S.-based CRO. Casimir has experience in more than 20 rare diseases and has worked with regulators, sponsors and patients to develop outcome measures that capture the nuan

52

52

pharmaphorum

MARCH 10, 2022

Mallinckrodt’s liability problems in the US have been lightened slightly, after it agreed a $260 million deal to resolve allegations of Medicare rebate fraud and payment of illegal kickbacks. The Ireland-domiciled company was accused of illegally paying smaller drug rebates to Medicaid than were due, as well as using a charitable foundation to cover co-pays for its Acthar Gel (corticotropin) epilepsy treatment – which is not allowed under US law.

105

105

Pharma Tutor

MARCH 8, 2022

Rice Ferment Filtrate in Cosmetics. About Author. Vinay Kumar Singh. . Head-Formulation. Kumar Organic Products Research Centre Pvt. Ltd., Bengaluru. admin. Tue, 03/08/2022 - 17:07. Tags. Articles.

52

52

Outsourcing Pharma

MARCH 9, 2022

A leader from the VCRO shares how far the industry has come with decentralized adoption, where opportunities for improvement exist, and what lies ahead.

52

52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Mirror

MARCH 11, 2022

The healthcare professions are rewarding, stimulating, prestigious, and lucrative. Few other professionals can say that their daily task is to save lives. The post Common Risks of Working as a Healthcare Professional appeared first on Pharma Mirror Magazine.

52

52

pharmaphorum

MARCH 6, 2022

As bluebird bio struggles to get its gene therapies over the finishing line, the company says its financial position raises “substantial doubt” about its ability to continue as a going concern. The biotech is sitting on around $442 million in liquid assets, but is expecting its cash burn in 2022 to be around $400 million, having recorded a net operating loss of $563 million last year.

FDA 105

FDA 105

Pharma Tutor

MARCH 6, 2022

Bioferments in Formula of Personal care Products. The virtues of fermentation within the human body are well known. It is proven good techniques for food, as Kimchi, Sauerkraut, Kefir, Idli & Dosa utilizes this technique. it is also significant for beauty products. The latest trend in Cosmetics particularly Skin Care is fermented beauty products. This concept, originated in Korea, basically involves fermentation of natural ingredients like black tea, ginseng, seaweed, bamboo sap extract, red clo

52

52

Outsourcing Pharma

MARCH 9, 2022

A leader from the Syneos Health company explains how innovative tech can elevate patient recruitment and engagement, even with the challenges DCTs can face.

52

52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Mirror

MARCH 7, 2022

With the recent pandemic lingering on, and the new devastating news of a potential global war, prioritizing your overall health and well-being has never been more critical. While the covid19 pandemic showed us just how important physical health and a robust immune system are, the news of the war is quickly showing us the importance of mental well-being.

Immunization 52

Immunization 52

pharmaphorum

MARCH 10, 2022

18 months after signing its first partnering deal with Genentech, Scenic Biotech has raised $31 million in first-round financing that it will use to take its own genetic modifier-targeted medicines into clinical trials. The Netherlands-based biotech, which is putting together a pipeline of genetic modifier drugs for cancer and rare diseases, said the new funding would also allow it to double its headcount to add clinical capabilities and move to a larger facility.

Immunization 98

Immunization 98

Roots Analysis

MARCH 6, 2022

Complement System: Key Component of Immune System. Complement system was discovered in 19th century as a part of immune system responsible for tissue repair and homeostasis, thereby providing first line of defense against multiple infections. This complete process is in association with a complex and highly regulated assembly of proteins which involve several soluble and surface-bound complement components, including receptors and regulators, which are majorly generated by the liver.

Immunization 52

Immunization 52

Outsourcing Pharma

MARCH 8, 2022

The drug company has renewed its arrangement with the artificial intelligence specialist, centered on using AI to improve understanding of the immune system.

Immunization 52

Immunization 52

Pharma Times

MARCH 9, 2022

Trodelvy is accepted for use in mTNBC patients who have already received two or more systemic therapies

51

51

pharmaphorum

MARCH 10, 2022

In little over three decades, advances in biotechnology have noticeably disrupted the development landscape of small molecule drugs. Yet, despite the immense potential of the field, biologics have remained largely untapped. Now, amid a wave of innovation, investors and drugmakers are putting their weight behind the drug class. “Biologics have revolutionised treatments for several serious diseases, some of which had no therapeutic alternatives until now,” says Antonio Magnelli, head of the Chiesi

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Packaging Immunization 98

Tria Health Blog

MARCH 9, 2022

Sleep Awareness Week is next week from March 13th– 19th. The National Sleep Foundation created this week to reemphasize the importance of the connection of sleep and health. Their theme this year is “Best Slept Self”.

40

40

Outsourcing Pharma

MARCH 8, 2022

The pharmaceutical company and the digital therapeutics specialist are joining forces to help accelerate the expansion of various digital health solutions.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Times

MARCH 11, 2022

93% of people suspected by GPs to have cancer should be seen by a specialist within two weeks but this has fallen to just 75%

48

48

pharmaphorum

MARCH 9, 2022

Sanofi and Sobi’s haemophilia partnership has been under competitive pressure from new therapies like Roche’s antibody Hemlibra, so the two companies are hoping a new long-acting drug candidate can revitalise the franchise. New phase 3 data on efanesoctocog alfa (also known as BIVV001) has met its objectives in a phase 3 study, providing protection from bleeding episodes in patients with haemophilia A with once-weekly dosing.

Labelling 98

Labelling FDA 98

Pharmacy Friday Pearls

MARCH 9, 2022

Download PDF. Introduction . 1. Around 9,000 Americans are treated for snake bites and 5 die each year. Most are bitten by members of the Crotalinae subfamily (a.k.a. crotalids) of the pit viper family which includes copperheads, water moccasins, and rattlesnakes. 2. Crotalid envenomation’s can cause broad range of adverse effects, including local tissue, hematologic, and/or systemic effects including shock and life-threatening bleeding. 3.

Immunization 40

Immunization Packaging Labelling FDA 40

Outsourcing Pharma

MARCH 8, 2022

Integrated research organization Circuit Clinical will standardize its decentralized operations with Medidataâs RAVE and myMedidata technological offerings.

52

52

Pharma Times

MARCH 10, 2022

Certain areas in the UK have been experiencing a significant increase in COVID-19 cases in recent days

47

47

pharmaphorum

MARCH 8, 2022

To celebrate International Women’s Day, we speak to design engineer at Envair Technology Darina Shopova; managing director, UK & ROI at Healthcare Business of Merck Doina Ionescu; and vice president of clinical development, medical, and regulatory affairs, Novo Nordisk UK Avideh Nazeri about their careers, how their field is progressing and how the industry can encourage more women and girls to pursue roles in STEM.

Hospitals 98

Hospitals Communication 98

Med Ed 101

MARCH 9, 2022

Alpha-blockers (i.e., tamsulosin) are commonly seen in male patients, as they are used to treat symptoms of benign prostatic hyperplasia (BPH; the only FDA-approved indication currently). Because of this, there is no doubt a prescription sent to the pharmacy for a female may raise some speculation. In recent years, uroselective alpha-blockers have been used for […].

FDA 40

FDA Labelling 40